Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Experimental Hematology|December 19, 2017
Acute myeloid leukemia xenograft success prediction: Saving timeEmmanuel Griessinger, Jacques Vargaftig, Stuart Horswell, et al.Leukemia|February 23, 2011
Heterogeneous sensitivity of human acute myeloid leukemia to β-catenin down-modulationArnaud Gandillet, Sophie Park, François Lassailly, et al.Stem Cells Translational Medicine|February 5, 2014
A niche-like culture system allowing the maintenance of primary human acute myeloid leukemia-initiating cells: a new tool to decipher their chemoresistance and self-renewal mechanismsEmmanuel Griessinger, Fernando Anjos-Afonso, Irene Pizzitola, et al.Aging Cell|March 23, 2011
Age-related changes in human hematopoietic stem/progenitor cellsKlaudia Kuranda, Jacques Vargaftig, Philippe de la Rochere, et al.Cancer Research|November 3, 2004
Absence or low expression of fas-associated protein with death domain in acute myeloid leukemia cells predicts resistance to chemotherapy and poor outcomeLéa Tourneur, Stéphanie Delluc, Vincent Lévy, et al.American Journal of Hematology|May 3, 2016
Efficacy and long-term toxicity of the rituximab-fludarabine-cyclophosphamide combination therapy in Waldenstrom's macroglobulinemiaLaetitia Souchet, Vincent Levy, Maya Ouzegdouh, et al.Haematologica|May 15, 2012
Intensive chemotherapy with thiotepa, busulfan and cyclophosphamide and hematopoietic stem cell rescue in relapsed or refractory primary central nervous system lymphoma and intraocular lymphoma: a retrospective study of 79 casesCarole Soussain, Sylvain Choquet, Emmanuelle Fourme, et al.Blood|January 8, 2010
Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fractionDavid C Taussig, Jacques Vargaftig, Farideh Miraki-Moud, et al.Cancer Research|March 11, 2016
Frequency and Dynamics of Leukemia-Initiating Cells during Short-term Ex Vivo Culture Informs Outcomes in Acute Myeloid Leukemia PatientsEmmanuel Griessinger, Fernando Anjos-Afonso, Jacques Vargaftig, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 24, 2024
Carfilzomib-associated thrombotic microangiopathy: clinical features and outcomesAdrien Joseph, Stéphanie Harel, Laurent Mesnard, et al.Pageof 2